According to the histologic subtype (Table 1), NRAS mutations are present in 31% of NMs, in 21% of superficial spreading melanomas (SSMs), in 8% of acral lentiginous melanomas (ALMs), and in 19% of Lentigo Malignas (LMs) [94]. This evidence concerns the gene NRAS and acral lentiginous melanoma.